Belite Bio, Inc (BLTE) — Financial statements
Income statement, balance sheet, and cash flow for Belite Bio, Inc — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 45↑51.6% | 30↑20.5% | 25↑180.1% | 9↑19.5% | 7 | |
| General & Administrative Expenses | 39↑286.1% | 10↑47.4% | 7↑72.7% | 4↑66.2% | 2 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 39↑286.1% | 10↑47.4% | 7↑72.7% | 4↑66.2% | 2 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 84↑110.5% | 40↑26.3% | 32↑147.0% | 13↑30.9% | 10 | |
| Total Costs & Expenses | 84↑110.5% | 40↑26.3% | 32↑147.0% | 13↑30.9% | 10 | |
| Operating Results | ||||||
| Operating Income | -84↓110.5% | -40↓26.3% | -32↓147.0% | -13↓30.9% | -10 | |
| Depreciation & Amortization | 0.00↓100.0% | 0.45↑12.5% | 0.40↑101.5% | 0.20↑560.0% | 0.03 | |
| EBITDA | -84↓136.1% | -36↓14.3% | -31↓150.9% | -12↓29.0% | -10 | |
| EBIT | -84↓133.1% | -36↓14.3% | -32↓150.1% | -13↓30.7% | -10 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↓100.0% | 4↑7485.7% | 0.05↑600.0% | 0.01↑40.0% | 0.01 | |
| Interest Income | 0.00↓100.0% | 4↑4950.0% | 0.07↑221.7% | 0.02↑360.0% | 0.01 | |
| Interest Expense | 0.00↓100.0% | 0.02↓20.0% | 0.03↑56.3% | 0.02 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -4↓5440.0% | -0.07↑63.0% | -0.19↓44.3% | -0.13 | |
| Other Income / Expenses | 7↑71.0% | 4↑8473.3% | 0.05↓74.0% | 0.17↑32.1% | 0.13 | |
| Income Before Tax | -78↓114.8% | -36↓14.3% | -32↓150.0% | -13↓30.9% | -10 | |
| Income Tax Expense | 0.00↓100.0% | 0.01↓33.3% | 0.01 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -78↓114.7% | -36↓14.3% | -32↓150.1% | -13↓30.9% | -10 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -78↓114.7% | -36↓14.3% | -32↓150.1% | -13↓30.9% | -10 | |
| Bottom-Line Net Income | -78↓114.7% | -36↓14.3% | -32↓150.1% | -13↓30.9% | -10 | |
| EPS (Basic) | -2.31↓95.8% | -1.18↑0.8% | -1.19↓88.9% | -0.63↓57.5% | -0.40 | |
| EPS (Diluted) | -2.31↓95.8% | -1.18↑0.8% | -1.19↓88.9% | -0.63↓57.5% | -0.40 | |
| Weighted Average Shares | 34↑9.8% | 31↑14.8% | 27↑33.1% | 20↓17.1% | 24 | |
| Weighted Average Diluted Shares | 34↑9.8% | 31↑14.8% | 27↑33.1% | 20↓17.1% | 24 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.